欢迎光临金融市场技术研究院
微信公众号
投资群
读书群
文章
  • 文章
  • 报告
  • 图书
  • 公募
  • 私募
  • 资讯
搜 索
上传文档
首页 文章 报告 图书 公募 私募 资讯
金融终端
您的当前位置：首页 > 研究报告 > 外盘报告 > 预览报告
20250324-招银国际-翰森制药-03692.HK-Overseas out-licensing as a sustainable profit driver.pdf
报告类型：港股公司研究 页数：5 文件大小：1.1M 上传时间：2025-08-07
机构：招银国际 作者：Jill Wu 5阅读 0收藏 0下载
下载PDF
下载全文所需积分：1
网友评论
{{Creator}}
{{Body}}
{{$val.TimeAgo({Dtime})}} [回复]
{{Creator}}： 回复 {{BeQuote}}
{{Body}}
{{$val.TimeAgo({Dtime})}} [回复]
上传用户
相关报告
20250324-招银国际-Driving quality growth.pdf 20250324-招银国际-伟仕佳杰-00856.HK-Strong FY24 results; benefiting from the robust AI demand.pdf 20250324-招银国际-4Q25 breakeven unlikely amid legacy burden.pdf 20250324-招银国际-众安在线-06060.HK-Tech export out of the red; ZA Bank on track for breakeven.pdf 20250324-招银国际-中国平安-02318.HK-Life OPAT awaits for longer time to turnaround.pdf 20250324-招银国际-贝克微-02149.HK-Record-high FY24 NPM of 28.8% underpins ability to maintain high margins.pdf 20250321-招银国际-Fixed Income Daily Market Update.pdf 20250324-招银国际-讯飞医疗科技-02506.HK-Leading the healthcare AI revolution; Initiate with BUY.pdf 20250324-招银国际-Fixed Income Daily Market Update.pdf 20250325-招银国际-华润饮料-02460.HK-FY24： Pleasant surprises from special dividends and target hike.pdf
mtachn.com
© 2013 mtachn,. All Rights Reserved.
苏ICP备48665885号-3
关于我们
学会宗旨 培训考试 联系方式
资源投稿
积分规则 投搞协议 评审标准
合作伙伴
微信公众号
{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=6229615","PageTitle":"20250324-招银国际-翰森制药-03692.HK-Overseas out-licensing as a sustainable profit driver.pdf-外盘报告 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":74,"Face":"/_files/face/0/iueb7ftt.jpg","UName":"卿妙婧","UpArts":0,"UpRpts":21031,"UpLbies":28},"Rid":6229615,"IsPdf":true,"IsExist":true,"PdfUrl":"/download2.mtachn.com/upload/report/外盘报告/20250324-招银国际-翰森制药-03692.HK-Overseas out-licensing as a sustainable profit driver.pdf","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}}